Title:
LAQUINIMOD COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS
Document Type and Number:
WIPO Patent Application WO/2015/065628
Kind Code:
A3
Abstract:
The subject invention provides a method for treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod and an amount of a compound of formula (I) : as described herein. The subject invention also provides packages and pharmaceutical compositions comprising laquinimod and a compound of formula (I) as described herein. The subject invention further provides uses of said compounds, pharmaceutical compositions and packages in treating a subject afflicted with a form of MS or presenting a CIS.
Inventors:
KNAPPERTZ VOLKER (US)
KAYE JOEL (IL)
KAYE JOEL (IL)
Application Number:
PCT/US2014/057705
Publication Date:
October 29, 2015
Filing Date:
September 26, 2014
Export Citation:
Assignee:
TEVA PHARMA (IL)
KNAPPERTZ VOLKER (US)
KAYE JOEL (IL)
KNAPPERTZ VOLKER (US)
KAYE JOEL (IL)
International Classes:
A61K31/225
Foreign References:
| US20130029916A1 | 2013-01-31 | |||
| US20080227847A1 | 2008-09-18 | |||
| US20120302600A1 | 2012-11-29 |
Other References:
See also references of EP 3049075A4
Attorney, Agent or Firm:
WHITE, John, P. (30 Rockefeller PlazaNew York, NY, US)
Download PDF: